166 related articles for article (PubMed ID: 1505460)
41. Parathyroid hormone modulation of 25-hydroxyvitamin D3 metabolism by cultured chick kidney cells is mimicked and enhanced by forskolin.
Henry HL
Endocrinology; 1985 Feb; 116(2):503-10. PubMed ID: 2981664
[TBL] [Abstract][Full Text] [Related]
42. Mouse osteoblastic cells (MC3T3-E1) at different stages of differentiation have opposite effects on osteoclastic cell formation.
Hiura K; Sumitani K; Kawata T; Higashino K; Okawa M; Sato T; Hakeda Y; Kumegawa M
Endocrinology; 1991 Mar; 128(3):1630-7. PubMed ID: 1999177
[TBL] [Abstract][Full Text] [Related]
43. High extracellular calcium stimulates osteoclast-like cell formation and bone-resorbing activity in the presence of osteoblastic cells.
Kaji H; Sugimoto T; Kanatani M; Chihara K
J Bone Miner Res; 1996 Jul; 11(7):912-20. PubMed ID: 8797111
[TBL] [Abstract][Full Text] [Related]
44. Osteoblastic control of osteoclast bone resorption in a serum-free co-culture system. Lack of effect of parathyroid hormone.
Teti A; Grano M; Colucci S; Zambonin Zallone A
J Endocrinol Invest; 1992; 15(9 Suppl 6):63-8. PubMed ID: 1300341
[No Abstract] [Full Text] [Related]
45. Effect of 24,25-dihydroxyvitamin D3 in osteoclasts.
Matsumoto T; Yamato H; Okazaki R; Kumegawa M; Ogata E
Proc Soc Exp Biol Med; 1992 Jun; 200(2):161-4. PubMed ID: 1579577
[TBL] [Abstract][Full Text] [Related]
46. Parathyroid hormone down-regulates 1,25-dihydroxyvitamin D receptors (VDR) and VDR messenger ribonucleic acid in vitro and blocks homologous up-regulation of VDR in vivo.
Reinhardt TA; Horst RL
Endocrinology; 1990 Aug; 127(2):942-8. PubMed ID: 2164926
[TBL] [Abstract][Full Text] [Related]
47. Parathyroid hormone sensitizes long bones to the stimulation of bone resorption by 1,25-dihydroxyvitamin D3.
van Leeuwen JP; Birkenhäger JC; Bos MP; van der Bemd GJ; Herrmann-Erlee MP; Pols HA
J Bone Miner Res; 1992 Mar; 7(3):303-9. PubMed ID: 1585831
[TBL] [Abstract][Full Text] [Related]
48. Carboxyl-terminal peptides from parathyroid hormone-related protein stimulate osteoclast-like cell formation.
Kaji H; Sugimoto T; Kanatani M; Fukase M; Chihara K
Endocrinology; 1995 Mar; 136(3):842-8. PubMed ID: 7867592
[TBL] [Abstract][Full Text] [Related]
49. Glucocorticoids and 1,25-dihydroxyvitamin D3 regulate parathyroid hormone stimulation of adenosine 3',5'-monophosphate-dependent protein kinase in rat osteosarcoma cells.
Titus L; Rubin JE; Lorang MT; Catherwood BD
Endocrinology; 1988 Sep; 123(3):1526-34. PubMed ID: 2456915
[TBL] [Abstract][Full Text] [Related]
50. Multinucleated cells formed on calcified dentine from mouse bone marrow cells treated with 1 alpha,25-dihydroxyvitamin D3 have ruffled borders and resorb dentine.
Sasaki T; Takahashi N; Higashi S; Suda T
Anat Rec; 1989 Jul; 224(3):379-91. PubMed ID: 2782622
[TBL] [Abstract][Full Text] [Related]
51. Effects of geranylgeranoic acid in bone: induction of osteoblast differentiation and inhibition of osteoclast formation.
Wang X; Wu J; Shidoji Y; Muto Y; Ohishi N; Yagi K; Ikegami S; Shinki T; Udagawa N; Suda T; Ishimi Y
J Bone Miner Res; 2002 Jan; 17(1):91-100. PubMed ID: 11771673
[TBL] [Abstract][Full Text] [Related]
52. Modulation of ecto-nucleoside triphosphate pyrophosphatase activity of human osteoblast-like bone cells by 1 alpha,25-dihydroxyvitamin D3, 24R,25-dihydroxyvitamin D3, parathyroid hormone, and dexamethasone.
Oyajobi BO; Russell RG; Caswell AM
J Bone Miner Res; 1994 Aug; 9(8):1259-66. PubMed ID: 7976508
[TBL] [Abstract][Full Text] [Related]
53. Posttranscriptional regulation of osteocalcin mRNA in clonal osteoblast cells by 1,25-dihydroxyvitamin D3.
Mosavin R; Mellon WS
Arch Biochem Biophys; 1996 Aug; 332(1):142-52. PubMed ID: 8806719
[TBL] [Abstract][Full Text] [Related]
54. The bone marrow-derived stromal cell lines MC3T3-G2/PA6 and ST2 support osteoclast-like cell differentiation in cocultures with mouse spleen cells.
Udagawa N; Takahashi N; Akatsu T; Sasaki T; Yamaguchi A; Kodama H; Martin TJ; Suda T
Endocrinology; 1989 Oct; 125(4):1805-13. PubMed ID: 2676473
[TBL] [Abstract][Full Text] [Related]
55. Increase of vascular endothelial growth factor mRNA expression by 1,25-dihydroxyvitamin D3 in human osteoblast-like cells.
Wang DS; Yamazaki K; Nohtomi K; Shizume K; Ohsumi K; Shibuya M; Demura H; Sato K
J Bone Miner Res; 1996 Apr; 11(4):472-9. PubMed ID: 8992878
[TBL] [Abstract][Full Text] [Related]
56. The chemokine Cxcl1 is a novel target gene of parathyroid hormone (PTH)/PTH-related protein in committed osteoblasts.
Onan D; Allan EH; Quinn JM; Gooi JH; Pompolo S; Sims NA; Gillespie MT; Martin TJ
Endocrinology; 2009 May; 150(5):2244-53. PubMed ID: 19147675
[TBL] [Abstract][Full Text] [Related]
57. Osteoblastic cells are involved in osteoclast formation.
Takahashi N; Akatsu T; Udagawa N; Sasaki T; Yamaguchi A; Moseley JM; Martin TJ; Suda T
Endocrinology; 1988 Nov; 123(5):2600-2. PubMed ID: 2844518
[TBL] [Abstract][Full Text] [Related]
58. Short-term treatment of rats with high dose 1,25-dihydroxyvitamin D3 stimulates bone formation and increases the number of osteoblast precursor cells in bone marrow.
Erben RG; Scutt AM; Miao D; Kollenkirchen U; Haberey M
Endocrinology; 1997 Nov; 138(11):4629-35. PubMed ID: 9348188
[TBL] [Abstract][Full Text] [Related]
59. A simple method to assess osteoclast-mediated bone resorption using unfractionated bone cells.
Takada Y; Kusuda M; Hiura K; Sato T; Mochizuki H; Nagao Y; Tomura M; Yahiro M; Hakeda Y; Kawashima H
Bone Miner; 1992 Jun; 17(3):347-59. PubMed ID: 1623329
[TBL] [Abstract][Full Text] [Related]
60. 1,25-Dihydroxyvitamin D3 [1,25-(OH)2D3] increases insulin-like growth factor I (IGF-I) receptors in clonal osteoblastic cells. Study on interaction of IGF-I and 1,25-(OH)2D3.
Kurose H; Yamaoka K; Okada S; Nakajima S; Seino Y
Endocrinology; 1990 Apr; 126(4):2088-94. PubMed ID: 2156680
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
